SCHEMBL63829

SCHEMBL63829

NCC(CN)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31024638 0.79
SCHEMBL63866 0.76
SCHEMBL17026010 0.75
SCHEMBL14432891 0.75
SCHEMBL23997437 0.73
SCHEMBL62461 0.71
SCHEMBL23391156 0.71
SCHEMBL3082701 0.69
SCHEMBL23376617 0.69
SCHEMBL12641439 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140193837-A1 LUMINESCENT NANOPARTICLE COMPOSITIONS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-07-10 US claimed
WO-2012174287-A1 LUMINESCENT NANOPARTICLE COMPOSITIONS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-12-20 WO claimed
US-7314959-B2 Amino thiol compounds and compositions for use in conjunction with cancer therapy WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-01-01 US claimed
US-20050101676-A1 Amino thiol compounds and compositions for use in conjunction with cancer therapy NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-05-12 US claimed
WO-2005014524-A2 AMINO THIOL COMPOUNDS AND COMPOSITIONS FOR USE IN CONJUNCTION WITH CANCER THERAPY WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2005-02-17 WO claimed
EP-4665295-A1 MODIFIED CROSSLINKED POLYMERS Lifesprout, Inc. (US) 2025-12-24 EP disclosed
WO-2024172910-A1 MODIFIED CROSSLINKED POLYMERS LIFESPROUT, INC. (US) 2024-08-22 WO disclosed
US-11690813-B2 Aminothiol reduction of ischemia-reperfusion-induced cell death Obvia Pharmaceuticals Ltd (US) 2023-07-04 US disclosed
US-11690813-B2 Aminothiol reduction of ischemia-reperfusion-induced cell death Obvia Pharmaceuticals Ltd (US) 2023-07-04 US disclosed
US-20230174562-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. 2023-06-08 US disclosed
US-20230174562-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. 2023-06-08 US disclosed
US-20230138150-A1 RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS Tonix Pharmaceuticals, Inc. 2023-05-04 US disclosed
US-8129869-B2 Electret and electrostatic induction conversion device ASAHI GLASS COMPANY, LIMITED (JP) 2012-03-06 US disclosed
US-20110166299-A1 ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE ASAHI GLASS COMPANY, LIMITED 2011-07-07 US disclosed
EP-2330159-A1 ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE Asahi Glass Company Limited (JP) 2011-06-08 EP disclosed
US-7314959-B2 Amino thiol compounds and compositions for use in conjunction with cancer therapy WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-01-01 US disclosed
US-7314959-B2 Amino thiol compounds and compositions for use in conjunction with cancer therapy WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-01-01 US disclosed
US-7314959-B2 Amino thiol compounds and compositions for use in conjunction with cancer therapy WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-01-01 US disclosed
US-20050101676-A1 Amino thiol compounds and compositions for use in conjunction with cancer therapy NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-05-12 US disclosed
WO-2005014524-A2 AMINO THIOL COMPOUNDS AND COMPOSITIONS FOR USE IN CONJUNCTION WITH CANCER THERAPY WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2005-02-17 WO disclosed